MYRIAD GENETICS, INC. Intangible Assets, Net (Excluding Goodwill)
MYRIAD GENETICS, INC. (MYGN) had Intangible Assets, Net (Excluding Goodwill) of $139.00 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2026-07-31
- 2026-06-30: Intangible Assets, Net (Excluding Goodwill) $139.00M.
- 2026-03-31: Intangible Assets, Net (Excluding Goodwill) $145.70M.
- 2025-12-31: Intangible Assets, Net (Excluding Goodwill) $153.40M.
- 2025-09-30: Intangible Assets, Net (Excluding Goodwill) $163.10M.
| Period end | Intangible Assets, Net (Excluding Goodwill) | Intangible Assets, Net (Excluding Goodwill) as first filed |
|---|---|---|
| 2026-06-30 | $139.00M 10-Q · filed 2026-07-31 | |
| 2026-03-31 | $145.70M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $153.40M 10-Q · filed 2026-07-31 | |
| 2025-09-30 | $163.10M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $170.10M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $257.50M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $262.40M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $312.50M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $319.50M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $340.90M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $349.50M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $356.60M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $358.80M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $369.40M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $379.70M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $370.80M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $382.30M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $393.60M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $404.10M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $414.80M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $426.80M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $559.90M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $576.50M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $590.90M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $605.30M 10-KT · filed 2021-03-16 | |
| 2020-03-31 | $620.00M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $653.50M 10-Q · filed 2020-02-07 | |
| 2019-09-30 | $667.80M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $684.70M 10-KT · filed 2021-03-16 | |
| 2019-03-31 | $699.50M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $717.60M 10-Q · filed 2019-02-06 | |
| 2018-09-30 | $734.20M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $455.20M 10-K · filed 2019-08-13 | |
| 2018-03-31 | $467.30M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $475.20M 10-Q · filed 2018-02-07 | |
| 2017-09-30 | $483.80M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $491.50M 10-K · filed 2018-08-24 | $491.60M 10-K · filed 2017-08-09 |
| 2017-03-31 | $498.10M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $506.40M 10-Q · filed 2017-02-08 | |
| 2016-09-30 | $521.20M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $227.50M 10-K · filed 2017-08-09 | |
| 2016-03-31 | $183.20M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $186.30M 10-Q · filed 2016-02-03 | |
| 2015-09-30 | $189.40M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $192.60M 10-K · filed 2016-08-10 | |
| 2015-03-31 | $195.69M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $198.83M 10-Q · filed 2015-02-04 | |
| 2014-09-30 | $201.96M 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $205.30M 10-K · filed 2015-08-12 | $205.31M 10-K · filed 2014-08-13 |
| 2014-03-31 | $208.30M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $12.84M 10-Q · filed 2014-02-05 | |
| 2013-09-30 | $13.09M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $13.33M 10-K · filed 2014-08-13 | |
| 2013-03-31 | $13.53M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $13.72M 10-Q · filed 2013-02-06 | |
| 2012-09-30 | $15.45M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $15.72M 10-K · filed 2013-08-14 | |
| 2012-03-31 | $15.99M 10-Q · filed 2012-05-02 | |
| 2011-12-31 | $16.27M 10-Q · filed 2012-02-01 | |
| 2011-09-30 | $16.44M 10-Q · filed 2011-11-02 | |
| 2011-06-30 | $16.71M 10-K · filed 2012-08-15 | |
| 2010-06-30 | $2.05M 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |